Needham & Company Reiterates a 'Buy' on Vivus (VVUS); Retrospective Topiramate Study to be Underway Soon, with Results Likely in 4Q11

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to Needham & Company Reiterates a 'Buy' on Vivus (VVUS); Retrospective Topiramate Study to be Underway Soon, with Results Likely in 4Q11
Vivus, Inc. (NASDAQ: VVUS) Delayed: 0.47 --0 (-0%)
Previous Close $0.47    52 Week High $1.85 
Open $44.85    52 Week Low $0.92 
Day High $0.47    P/E N/A 
Day Low $0.47    EPS $-2.13 
Volume 1,328